Epigenetic modulators provide a path to understanding disease and therapeutic opportunity
Genes & Development · 01.06.2024 · 38 (11-12) · 473-503
DOI: 10.1101/gad.351444.123 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Genes & Development, online erschienen am 24.06.2024. Verfasst von Madison A Honer und 4 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Epigenetics Institute, Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111, USA. Hauptthemen laut MEDLINE: Epigenesis, Genetic. Die Arbeit wurde bisher 48-mal zitiert (Crossref) und nennt 385 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIGMS NIH HHS, National Institutes of Health/National Cancer Institue Cancer Center.
Abstract (Originalsprache)
The discovery of epigenetic modulators (writers, erasers, readers, and remodelers) has shed light on previously underappreciated biological mechanisms that promote diseases. With these insights, novel biomarkers and innovative combination therapies can be used to address challenging and difficult to treat disease states. This review highlights key mechanisms that epigenetic writers, erasers, readers, and remodelers control, as well as their connection with disease states and recent advances in associated epigenetic therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Cancer Epigenetics Institute, Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111, USA.
- Nuclear Dynamics and Cancer Program, Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111, USA.
- Institute for Cancer Research, Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111, USA.
- Biomedical Sciences Program, Lewis Katz School of Medicine, Temple University, Philadelphia, Pennsylvania 19140, USA.
- Cancer Epigenetics Institute, Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111, USA; johnathan.whetstine@fccc.edu.
Förderung
- NCI NIH HHS
- NIGMS NIH HHS
- National Institutes of Health/National Cancer Institue Cancer Center
Zitieren
APA
Honer, M. A., Ferman, B. I., Gray, Z. H., Bondarenko, E. A., & Whetstine, J. R. (2024). Epigenetic modulators provide a path to understanding disease and therapeutic opportunity. Genes & Development, 38(11-12), 473-503. https://doi.org/10.1101/gad.351444.123
Vancouver
Honer MA, Ferman BI, Gray ZH, Bondarenko EA, Whetstine JR. Epigenetic modulators provide a path to understanding disease and therapeutic opportunity. Genes & Development. 2024;38(11-12):473-503. doi:10.1101/gad.351444.123
BibTeX
@article{Honer2024,
author = {Honer, Madison A and Ferman, Benjamin I and Gray, Zach H and Bondarenko, Elena A and Whetstine, Johnathan R},
title = {Epigenetic modulators provide a path to understanding disease and therapeutic opportunity},
journal = {Genes & Development},
year = {2024},
volume = {38},
number = {11-12},
pages = {473--503},
doi = {10.1101/gad.351444.123}
}
EUVIMED